Crohn Disease

Immunology·MeSH: Crohn Disease

Prevalence

201.0 / 100K

Incidence

6.0 / 100K/yr

55 drugs in development·13 companies·18 clinical trials

Drug Pipeline by Phase

Phase 3(8)

Drug	Company
AZD7798	ASTRAZENECA PLC (AZN)
icotrokinra	GH Research PLC (GHRS)
jnj-78934804	GH Research PLC (GHRS)
Mesna	Filana Therapeutics Inc. (FLNA)
Other Biologic Therapies	ENANTA PHARMACEUTICALS INC (ENTA)
risankizumab	GH Research PLC (GHRS)
tev-48574	Teva Pharmaceutical Industries Limited (TEVA)
Ustekinumab	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 2(19)

Drug	Company
Acetaminophen	ENANTA PHARMACEUTICALS INC (ENTA)
Cytoxan	Filana Therapeutics Inc. (FLNA)
Cytoxan	ENANTA PHARMACEUTICALS INC (ENTA)
db-3q	HCW Biologics Inc. (HCWB)
Diphenhydramine	ENANTA PHARMACEUTICALS INC (ENTA)
Diphenhydramine	Filana Therapeutics Inc. (FLNA)
Diphenhydramine	PROTHENA CORP PUBLIC LTD CO (PRTA)
Diphenhydramine	Cidara Therapeutics, Inc. (CDTX)
ly4395089	ELI LILLY & Co (LLY)
mirikizumab -	ELI LILLY & Co (LLY)
obefazimod	Abivax SA (ABVX)
Obefazimod	Abivax SA (ABVX)
Obefazimod 50 mg Capsule	Abivax SA (ABVX)
obefazimod mini	Abivax SA (ABVX)
obefazimod mini	Abivax SA (ABVX)
Peripheral Blood Stem Cell Infusion	Filana Therapeutics Inc. (FLNA)
tev-48574 dose regimen a	Teva Pharmaceutical Industries Limited (TEVA)
tev-48574 dose regiment b	Teva Pharmaceutical Industries Limited (TEVA)
vtx958	Ventyx Biosciences, Inc. (VTYX)

Phase 1(26)

Drug	Company
[11C]AZ14132516	ASTRAZENECA PLC (AZN)
Anti-STEAP1 CAR T-cells	Filana Therapeutics Inc. (FLNA)
anti-thymocyte globulin	Cidara Therapeutics, Inc. (CDTX)
anti-thymocyte globulin	PROTHENA CORP PUBLIC LTD CO (PRTA)
anti-thymocyte globulin	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Cytoxan	Cidara Therapeutics, Inc. (CDTX)
Cytoxan	PROTHENA CORP PUBLIC LTD CO (PRTA)
Cytoxan	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Cytoxan	Structure Therapeutics Inc. (GPCR)
Diphenhydramine	Structure Therapeutics Inc. (GPCR)
Filgrastim	PROTHENA CORP PUBLIC LTD CO (PRTA)
Filgrastim	Cidara Therapeutics, Inc. (CDTX)
Filgrastim	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Fludarabine	Cidara Therapeutics, Inc. (CDTX)
Fludarabine	PROTHENA CORP PUBLIC LTD CO (PRTA)
Fludarabine	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
lymphocyte immune globulin	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
lymphocyte immune globulin	Cidara Therapeutics, Inc. (CDTX)
lymphocyte immune globulin	PROTHENA CORP PUBLIC LTD CO (PRTA)
lymphocyte immune globulin	Filana Therapeutics Inc. (FLNA)
Mesna	Structure Therapeutics Inc. (GPCR)
Mesna	ENANTA PHARMACEUTICALS INC (ENTA)
Mesna	PROTHENA CORP PUBLIC LTD CO (PRTA)
Mesna	Cidara Therapeutics, Inc. (CDTX)
Mesna	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Peripheral Blood Stem Cell Infusion	PROTHENA CORP PUBLIC LTD CO (PRTA)

Phase 4(2)

Drug	Company
Acetaminophen	Structure Therapeutics Inc. (GPCR)
guselkumab	GH Research PLC (GHRS)

BioSniper tracks 55 drugs in development for Crohn Disease across 13 companies.

There are 18 clinical trials targeting Crohn Disease tracked by BioSniper.

The estimated prevalence of Crohn Disease is approximately 201.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.